Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemically Recurrent Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04206319
What this trial is testing

Radium-223 in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemical Recurrent Prostate Cancer
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Ended earlyNCT04336943
What this trial is testing

Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
University of Washington 6
Very early researchLooking for participantsNCT06813898
What this trial is testing

An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
Northwestern University 27
Testing effectiveness (Phase 2)Study completedNCT04050215
What this trial is testing

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more
Jonsson Comprehensive Cancer Center 937
Large-scale testing (Phase 3)Study completedNCT00672282
What this trial is testing

Casodex vs Placebo in Non-Metastatic Early Prostate Cancer

Who this might be right for
Non-Metastatic Prostate Cancer
AstraZeneca 1,218
Not applicableStudy completedNCT04447703
What this trial is testing

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaStage IIIB Prostate Cancer AJCC v8+2 more
Thomas Jefferson University 346
Large-scale testing (Phase 3)Looking for participantsNCT07831824
What this trial is testing

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

Who this might be right for
Prostate Cancer
Lantheus Medical Imaging 408
Large-scale testing (Phase 3)Active Not RecruitingNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Not applicableLooking for participantsNCT07538843
What this trial is testing

An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

Who this might be right for
Non-metastatic Castration-resistant Prostate Cancer
Bayer 800
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Early research (Phase 1)Study completedNCT02141659
What this trial is testing

TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

Who this might be right for
Hormone Treatment-naïve Participants With Prostate Cancer
Takeda 43
Testing effectiveness (Phase 2)WithdrawnNCT00771017
What this trial is testing

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00814892
What this trial is testing

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 2
Not applicableLooking for participantsNCT06202248
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.

Who this might be right for
Non-metastatic Prostate CancerLocally Recurrent Prostate Cancer
Alpha Tau Medical LTD. 10
Not applicableWithdrawnNCT00161252
What this trial is testing

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Looking for participantsNCT07751159
What this trial is testing

Radiation Therapy Approaches for People With Prostate Cancer

Who this might be right for
Prostate Cancer PatientsNon-metastatic Prostate CancerHigh Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center 126
Large-scale testing (Phase 3)Ended earlyNCT00236002
What this trial is testing

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Who this might be right for
Osteoporosis
Canadian Urology Research Consortium 182
Testing effectiveness (Phase 2)Ended earlyNCT03810105
What this trial is testing

Olaparib and Durvalumab in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5
Testing effectiveness (Phase 2)Looking for participantsNCT06220188
What this trial is testing

PSMA-RLT in Biochemically Recurrent PCa

Who this might be right for
Prostate Cancer Recurrent
Medical University of Vienna 20
Next Page